Brief: Expres2ion Biotech Q2 Pre-Tax Loss Widens To SEK 10.1 Mln
Aug 19 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* Q2 OPERATING INCOME SEK 4.8 MILLION VERSUS SEK 4.0 MILLION
YEAR
AGO
* EXPRES2ION ANNOUNCES FINANCIAL RESULTS FOR THE SECOND
QUARTER OF
2021
* Q2 PRE-TAX LOSS SEK 10.1 MILLION VERSUS LOSS SEK 5.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr2RcwQL
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations